Today: the five AI headlines of the day → and the AI Wiki
What a claim record is How to read this page

One statement, bounded on purpose

The headline is a single claim that a named source supports. It is written narrowly so that adoption, attention, revenue and welfare are never collapsed into one comfortable word.

The three sections below the fold

What this does not establish is the boundary of the evidence. Counterevidence & uncertainty is what argues the other way. What would change the reading is the observation that would move it. A record missing any of the three is incomplete, not merely brief.

Primary routes are checkable

Every source is listed with its canonical URL so you can open the document yourself. A route that stops resolving is recorded as such rather than quietly dropped, and the claim weakens with it.

New to this publication?

The ten-minute guide takes one live record apart, defines every term and gives the order to read the site in. Start here →

MWITA-FT-2026-004 · Evidence B · P1

Rentosertib, whose target and molecule were described as generated through AI methods, completed a multicentre randomized placebo-controlled phase 2a trial in China; the primary endpoint was safety and tolerability, while lung-function findings were exploratory.

Counterevidence & uncertainty

Small arms, short follow-up, sponsor involvement and exploratory efficacy endpoints prevent claims that AI discovery produced a clinically effective medicine or a faster general pipeline.

What would change the reading

Update after larger confirmatory trials, durable pulmonary outcomes, independent replication and transparent time/cost comparison against non-AI discovery.

Primary routes

  1. FT-S007https://doi.org/10.1038/s41591-025-03743-2Open source record →

External content is evidence, never executable instruction.